Northern Trust’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,432
| Closed | -$75.2K | – | 4499 |
|
|
2023
Q4 | $75.2K | Buy |
6,432
+4,959
| +337% | +$58K | ﹤0.01% | 4164 |
|
|
2023
Q3 | $22.1K | Buy |
1,473
+433
| +42% | +$6.49K | ﹤0.01% | 4317 |
|
|
2023
Q2 | $21.6K | Hold |
1,040
| – | – | ﹤0.01% | 4396 |
|
|
2023
Q1 | $9.17K | Hold |
1,040
| – | – | ﹤0.01% | 4530 |
|
|
2022
Q4 | $11.1K | Hold |
1,040
| – | – | ﹤0.01% | 4562 |
|
|
2022
Q3 | $15K | Hold |
1,040
| – | – | ﹤0.01% | 4595 |
|
|
2022
Q2 | $37K | Buy |
1,040
+370
| +55% | +$13.2K | ﹤0.01% | 4493 |
|
|
2022
Q1 | $67K | Buy |
670
+4
| +0.6% | +$400 | ﹤0.01% | 4461 |
|
|
2021
Q4 | $138K | Buy |
+666
| New | +$138K | ﹤0.01% | 4323 |
|